---
title: "Hims & Hers Surges 40.79% on Weight-Loss Drug Deal, AZI Skyrockets 146.40%"
canonical_url: https://www.stockexpertai.com/journal/2026-03-10/hims-hers-surges-4079-on-weight-loss-drug-deal-azi-skyrockets-14640
last_updated: 2026-03-10T06:05:39.328Z
section: "Earnings Watch"
author: "Taylor Brooks"
publisher: Stock Expert AI
tickers: HIMS, AZI, ORCL, ROKU, JOBY, PRTH, DOMO, RDNW, BLND
content_type: journal-article
---

# Hims & Hers Surges 40.79% on Weight-Loss Drug Deal, AZI Skyrockets 146.40%

## The Take
- Pay attention to individual company news and sector-specific developments as earnings season unfolds, as company-specific news can drive substantial stock movements.

_Earnings season continues with impressive gains and key sector movements._

Earnings season brings clarity—and volatility. Several companies have recently reported or are about to report earnings, driving significant movements in their respective stock prices. Here's a look at two notable movers: Hims & Hers and Autozi.

Hims & Hers Health (HIMS) experienced a massive surge of 40.79%, closing at $22.16. This jump follows the announcement that Novo Nordisk will sell its weight-loss drug through Hims & Hers' telehealth platform, resolving a patent dispute. This move significantly expands Hims & Hers' offerings in the high-demand weight management market, boosting investor confidence.

Autozi (AZI) also saw substantial gains, skyrocketing 146.40% to $0.65. This impressive climb comes after the company's controlling shareholder completed a $7 million capital injection, fulfilling a prior commitment. The shareholder also pledged an additional $110 million at $1.30 per share, signaling strong confidence in Autozi's future prospects. These capital injections provide Autozi with the financial resources needed to pursue its growth strategies.

While HIMS and AZI posted impressive gains, other companies experienced more muted reactions. Oracle (ORCL) shares fell 0.92% to $151.56 as analysts cut price targets ahead of the company's upcoming earnings release. Roku (ROKU) dipped slightly by 0.40% to $100.17 despite announcing the addition of Apple TV to its Premium Subscriptions. Joby Aviation (JOBY) increased 5.13% to $10.04 after being selected for the White House-backed eVTOL Integration Pilot Program. These varied reactions highlight the stock-specific nature of earnings season and the importance of understanding individual company dynamics. SPY is up 0.88% to $678.27. QQQ is up 1.34% to $607.76. DIA is up 0.56% to $477.88. IWM is up 1.09% to $253.62.

Expectations are set. Now comes execution.

## Related Tickers
- [HIMS](https://www.stockexpertai.com/stock/hims)
- [AZI](https://www.stockexpertai.com/stock/azi)
- [ORCL](https://www.stockexpertai.com/stock/orcl)
- [ROKU](https://www.stockexpertai.com/stock/roku)
- [JOBY](https://www.stockexpertai.com/stock/joby)
- [PRTH](https://www.stockexpertai.com/stock/prth)
- [DOMO](https://www.stockexpertai.com/stock/domo)
- [RDNW](https://www.stockexpertai.com/stock/rdnw)
- [BLND](https://www.stockexpertai.com/stock/blnd)

## Frequently Asked Questions

### Why did Hims & Hers stock price increase?
Hims & Hers (HIMS) stock surged due to a deal with Novo Nordisk to sell its weight-loss drug on the Hims & Hers telehealth platform. This resolves a patent dispute and expands their offerings in the weight management market, boosting investor confidence. The stock closed at $22.16, up 40.79%.

### What is Autozi (AZI) and why did its stock price increase?
Autozi (AZI) saw a significant increase in its stock price, skyrocketing 146.40% to $0.65. This rise is attributed to a $7 million capital injection from the company's controlling shareholder, fulfilling a prior commitment. The shareholder also pledged an additional $110 million, signaling confidence in Autozi's future growth.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._